BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31620846)

  • 1. Imaging surveillance for children with predisposition to renal tumors.
    Srinivasan AS; Saade-Lemus S; Servaes SE; Acord MR; Reid JR; Anupindi SA; States LJ
    Pediatr Radiol; 2019 Oct; 49(11):1453-1462. PubMed ID: 31620846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of cancer predisposition syndromes.
    Greer MC
    Pediatr Radiol; 2018 Aug; 48(9):1364-1375. PubMed ID: 30078044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body magnetic resonance imaging of pediatric cancer predisposition syndromes: special considerations, challenges and perspective.
    Saade-Lemus S; Degnan AJ; Acord MR; Srinivasan AS; Reid JR; Servaes SE; States LJ; Anupindi SA
    Pediatr Radiol; 2019 Oct; 49(11):1506-1515. PubMed ID: 31620850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging findings of hereditary renal tumors, a review of what the radiologist should know.
    Czarniecki M; Gautam R; Choyke PL; Turkbey B
    Eur J Radiol; 2018 Apr; 101():8-16. PubMed ID: 29571805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of cancer predisposition syndromes in children.
    Monsalve J; Kapur J; Malkin D; Babyn PS
    Radiographics; 2011; 31(1):263-80. PubMed ID: 21257945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary renal tumors: More common than expected?].
    Agaimy A; Hartmann A
    Pathologe; 2016 Mar; 37(2):134-43. PubMed ID: 26979427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of cancer predisposition syndromes.
    Al-Sarhani H; Gottumukkala RV; Grasparil ADS; Tung EL; Gee MS; Greer MC
    Pediatr Radiol; 2022 Feb; 52(2):401-417. PubMed ID: 33791839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model.
    McNeil DE; Brown M; Ching A; DeBaun MR
    Med Pediatr Oncol; 2001 Oct; 37(4):349-56. PubMed ID: 11568898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging for Screening and Surveillance of Patients with Hereditary Forms of Renal Cell Carcinoma.
    Freifeld Y; Ananthakrishnan L; Margulis V
    Curr Urol Rep; 2018 Aug; 19(10):82. PubMed ID: 30116909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations.
    Bardón-Cancho EJ; Haro-Díaz A; Alonso-García-de la Rosa FJ; Huerta-Aragonés J; García-Morín M; González-Martínez F; Garrido-Colino C
    Fam Cancer; 2017 Apr; 16(2):291-294. PubMed ID: 27830405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Hippel-Lindau Disease: Review of Genetics and Imaging.
    Shanbhogue KP; Hoch M; Fatterpaker G; Chandarana H
    Radiol Clin North Am; 2016 May; 54(3):409-22. PubMed ID: 27153780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma.
    Kalish JM; Doros L; Helman LJ; Hennekam RC; Kuiper RP; Maas SM; Maher ER; Nichols KE; Plon SE; Porter CC; Rednam S; Schultz KAP; States LJ; Tomlinson GE; Zelley K; Druley TE
    Clin Cancer Res; 2017 Jul; 23(13):e115-e122. PubMed ID: 28674120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic predisposition to childhood cancer].
    Ripperger T; Schlegelberger B
    Pathologe; 2018 Dec; 39(Suppl 2):306-310. PubMed ID: 30397787
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Schultz KAP; Williams GM; Kamihara J; Stewart DR; Harris AK; Bauer AJ; Turner J; Shah R; Schneider K; Schneider KW; Carr AG; Harney LA; Baldinger S; Frazier AL; Orbach D; Schneider DT; Malkin D; Dehner LP; Messinger YH; Hill DA
    Clin Cancer Res; 2018 May; 24(10):2251-2261. PubMed ID: 29343557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician.
    Teplick A; Kowalski M; Biegel JA; Nichols KE
    Eur J Pediatr; 2011 Mar; 170(3):285-94. PubMed ID: 21210147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predisposition to pediatric and hematologic cancers: a moving target.
    Malkin D; Nichols KE; Zelley K; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2014; ():e44-55. PubMed ID: 24857136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA Cancer Committee.
    Grant CN; Rhee D; Tracy ET; Aldrink JH; Baertschiger RM; Lautz TB; Glick RD; Rodeberg DA; Ehrlich PF; Christison-Lagay E
    J Pediatr Surg; 2022 Mar; 57(3):430-442. PubMed ID: 34503817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genitourinary manifestations of hereditary cancer predisposition syndromes in children.
    Gillespie NJ; Van Mater D
    Transl Androl Urol; 2020 Oct; 9(5):2331-2347. PubMed ID: 33209707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
    Rednam SP; Erez A; Druker H; Janeway KA; Kamihara J; Kohlmann WK; Nathanson KL; States LJ; Tomlinson GE; Villani A; Voss SD; Schiffman JD; Wasserman JD
    Clin Cancer Res; 2017 Jun; 23(12):e68-e75. PubMed ID: 28620007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
    Maher ER
    World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.